The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition

Sodium–glucose cotransporter 2 inhibitors (SGLT2i) effectively lower plasma glucose (PG) concentration in patients with type 2 diabetes, but studies have suggested that circulating glucagon concentrations and endogenous glucose production (EGP) are increased by SGLT2i, possibly compromising their gl...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes
Main Authors: Hædersdal, Sofie, Lund, Asger, Nielsen-Hannerup, Elisabeth, Maagensen, Henrik, van Hall, Gerrit, Holst, Jens J., Knop, Filip K., Vilsbøll, Tina
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2020
Teme:
Metabolism
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7679772/
https://ncbi.nlm.nih.gov/pubmed/33004472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db20-0369
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki